LTLeabaneng Tawe

Leabaneng Tawe

*This is an algorithmically generated author record based on publicly available information.

Leabaneng Tawe has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mapping the HPV Detection Landscape in Botswana: A Narrative Review of Diagnostic Platforms and Their Impact on Cervical Cancer Control

    by Leabaneng Tawe

    Background and Aim: Cervical cancer is a major public health issue in Botswana, driven by high HIV prevalence and limited screening access. Molecular detection of high‐risk human papillomavirus (hrHPV) is crucial for prevention and early diagnosis. The aim of this narrative review is to synthesize studies evaluating seven HPV detection platforms used in Botswana, focusing on diagnostic performance, feasibility, and scalability. Methods: A comprehensive literature search was conducted across PubMed, PMC, Google Scholar, and regional repositories up to July 2025 to identify studies evaluating HPV detection platforms in Botswana. Eligible studies included those assessing molecular HPV assays or genotyping tools in Botswana populations, reporting diagnostic performance or feasibility data. Data extracted covered study population characteristics, sample types, detection platforms, hrHPV prevalence, and performance metrics. Findings were qualitatively synthesized to compare platforms by sample type and application, as heterogeneity precluded meta‐analysis. Results: The Cepheid Xpert HPV assay, with near‐point‐of‐care capability, self‐sampling suitability, and high sensitivity (96%) and specificity (90%), is well‐suited for national programs despite costs of $15–$25 per test. AmpFire, costing $10–$15 per test, requires minimal equipment, offers good field feasibility (92% sensitivity, 88% specificity), and is promising for community deployment. Laboratory‐based assays like Roche Linear Array and Abbott RealTime deliver broader genotyping and > 93% sensitivity but require centralized infrastructure. PathoChip microarray detects novel HPV types yet is cost‐prohibitive (> $150/test). Double‐nested PCR aids retrospective formalin‐fixed paraffin‐embedded (FFPE) analysis but lacks practicality. These platforms collectively enhance cervical cancer prevention strategies in Botswana. Conclusions: This review identifies feasible HPV detection platforms for Botswana's cervical cancer control. Cepheid Xpert and AmpFire assays offer accurate, affordable, and field‐ready options for early diagnosis and wider screening access. Integrating these molecular tools into existing HIV and reproductive health services could enhance prevention, early detection, and progress toward WHO cervical cancer elimination goals.

  • Sickle Cell Disease and Hemoglobin S Prevalence in Botswana

    by Setho Ruth Taboka Kgakatsi, Somolekae Katlego Galetlale, Leabaneng Tawe, Ishmael Kasvosve, Jeremy Seth Slone, Isaac Kweku Quaye, Giacomo Maria Paganotti

    Introduction: Sickle cell disease is an autosomal recessive blood disorder due to a mutation in the gene encoding the β‐globin chain. Epidemiological studies suggest that individuals with the sickle traits have protection against severe and uncomplicated Plasmodium falciparum malaria. In Botswana, the frequency of the HbS allele remains unknown. This study aimed to determine the frequency of the HbS allele in the Ngami and Okavango health districts, areas with relatively high malaria incidence. Method: Residual DNA samples previously collected from asymptomatic children during a Malaria Indicator Survey were used for this study, with variant detection conducted via PCR‐restriction fragment length polymorphism analysis. Results: A total of 159 samples were analyzed, 79 from Ngami and 80 from Okavango. The results showed that 98.1% of the study subjects had the wild type (Hb‐AA) alleles, 1.9% carried sickle cell trait (Hb‐AS), and none had homozygous sickle cell (Hb‐SS). The frequency of the S allele was found to be 0.0094. Conclusions: The presence of the S allele in Botswana, albeit at a low frequency, suggests that sickle cell disease can be a potential contributor to chronic hemolytic disorders in Botswana.

  • Open Access

    Alterations of the upper respiratory microbiome among children living with HIV infection in Botswana

    by Sweta M. Patel, John Farirai, Mohamed Z. Patel, Sefelani Boiditswe, Leabaneng Tawe, Shimane Lekalake, Mogomotsi Matshaba, Andrew P. Steenhoff, Tonya Arscott-Mills, Kristen A. Feemster, et al.

    Children living with HIV (CLWH) are at high risk of colonization and infection by bacterial respiratory pathogens, though this risk can be reduced by other microbes in the upper respiratory microbiome. The impact of HIV infection on development of the upper respiratory microbiome during childhood is poorly understood, and we sought to address this knowledge gap by identifying associations between HIV infection and the nasopharyngeal microbiomes of children in Botswana. We enrolled Batswana CLWH (Corynebacterium species associated with respiratory health. These findings suggest that the upper respiratory microbiome may contribute to the high risk of bacterial respiratory infections among CLWH.